← Evidence map

ArticleFrontiers in public health2025

Can the Marketing Authorisation Holder system improve the ESG performance of pharmaceutical manufacturers?

Jiajing LiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40567990